Association Between the Risk of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease
DOI: https://doi.org/10.2147/DMSO.S356497
2022-04-14
Abstract:Pingping Zhao, 1 Junxin Yan, 1 Binjing Pan, 1 Jingfang Liu, 1, 2 Songbo Fu, 1, 2 Jianguo Cheng, 1, 2 Liting Wang, 1, 2 Gaojing Jing, 1, 2 Qiong Li 1, 2 1 The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, People's Republic of China; 2 Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, People's Republic of China Correspondence: Jingfang Liu, Department of Endocrinology, the First Hospital of Lanzhou University, Lanzhou, Gansu, 730000, People's Republic of China, Tel +86 931-8356242, Email Objective: To explore the relationship between non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD) in patients with type 2 diabetes mellitus (T2DM). Methods: A total of 1168 patients with T2DM were divided into the non-CKD and CKD groups, and the difference in the prevalence of NAFLD was compared. The differences in serum creatinine (SCr) and urine albumin-to-creatinine ratio (UACR) levels were compared between the non-NAFLD and NAFLD groups. Patients with T2DM were divided into three groups according to their UACR levels (UACR < 30 mg/g [U1 group]; UACR ≤ 30 mg/g to < 300 mg/g [U2 group]; and UACR ≥ 300 mg/g [U3 group]) or estimated glomerular filtration rate (eGFR) levels (≥ 90 mL/min [G1 group]; eGFR ≤ 60 mL/min to < 90 mL/min [G2 group]; and eGFR < 60 mL/min (G3 group]). The difference in the prevalence and risks of NAFLD in the different UACR or eGFR level groups was analyzed. Results: The prevalence of NAFLD in the CKD group was higher than that in the non-CKD group (63.5% vs 50.5%, p < 0.001). The SCr and UACR levels in the NAFLD group were higher than those in the non-NAFLD group (both p < 0.05). The prevalence of NAFLD in the U3 group (75.6%) was higher than that in the U1 (50.5%, p < 0.05) and U2 (60.1%, p < 0.05) groups, and the prevalence of NAFLD in the U2 group (60.1%) was higher than that in the U1 group (50.5%, p < 0.05). The risk of NAFLD in the U3 group was higher than that in the U2 group (odds ratio [OR] = 3.032 and 1.473). Despite adjusting the parameters further, the NAFLD risk in the U3 group remained higher than that in the U2 group (OR = 1.660 and 2.342). Conclusion: The risk of NAFLD in patients with T2DM is closely related to CKD. Keywords: type 2 diabetes, non-alcoholic fatty liver disease, chronic kidney disease According to a report by the International Diabetes Federation in 2019, there are approximately 463 million patients with diabetes worldwide, 90% of whom have type 2 diabetes mellitus (T2DM). The number of patients with diabetes in China is approximately 129.8 million, accounting for a quarter of the global total. Diabetes mellitus has become an important public health problem. 1 Chronic kidney disease (CKD) secondary to diabetes has become the main cause of end-stage renal disease in China. 2 It has been reported that 20–40% of patients with diabetes will eventually develop kidney damage. 3,4 According to a survey of more than 60,000 patients with T2DM in 28 countries, the prevalence rate of CKD was 27.9%. 5 In the United States, its prevalence was 23.7%, according to the National Nutrition and Health Survey. 5,6 Meanwhile, a retrospective survey of chronic complications of T2DM conducted by the Chinese Diabetes Association in 2001 showed that the prevalence of renal complications in patients with T2DM in tertiary hospitals was 34.7%. 7 Non-alcoholic fatty liver disease (NAFLD) is a chronic metabolic disease closely related to insulin resistance (IR) and one of the causes of CKD. 8–10 Furthermore, NAFLD is associated with an increased risk of T2DM 11,12 and increased prevalence and morbidity of CKD. 13–15 However, a negative correlation has also been found between NAFLD and the prevalence of diabetic retinopathy or nephropathy in Korean and Iranian patients with T2DM, 16,17 and another study showed that there is no relationship between CKD and NAFLD. 18 Thus, the relationship between CKD and NAFLD remains controversial. Most scholars believe that the relationship between NAFLD and CKD is bidirectional in patients with T2DM. 19 The same pathogenic mechanisms between CKD and NAFLD were revealed, such as excessive oxidative stress, out of control renin-angiotensin-aldosterone system (renin-angiotensin-aldosterone system, [RAAS]), and changes in intestinal flora. 20 This study aimed to explore the relationship between NAFLD and CKD in patients with T2DM. A total -Abstract Truncated-